Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/06/2005CA2179778C Deuterised active agents in transdermal application
09/06/2005CA2160034C Gibbon ape leukemia virus-based retroviral vectors
09/06/2005CA2137673C Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives
09/06/2005CA2127536C Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists
09/06/2005CA2119516C Ointment for wound treatment
09/06/2005CA2105652C Reducing wound scarring with antibodies to growth factors
09/06/2005CA2086137C Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
09/06/2005CA2067690C Amino acid derivatives
09/04/2005CA2491341A1 Topical formulations for treatment of rosacea
09/03/2005CA2498177A1 Amorphous 3-pyridil-1-hydroxyethyliden-1,1-biphosphonic acid monosodium salt and process for the preparation thereof
09/03/2005CA2457303A1 Transductin-1 and transductin-2 and applications to hereditary deafness
09/01/2005WO2005080984A1 Modulators of angiogenesis and tumorigenesis
09/01/2005WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
09/01/2005WO2005080972A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions
09/01/2005WO2005080890A1 Pharmacologically acceptable salts of clopidogrel
09/01/2005WO2005080582A1 Cytoplasmic localization dna and rna
09/01/2005WO2005080573A1 Recombinant viral vectors to promote neuronal cell survival and uses thereof
09/01/2005WO2005080567A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals
09/01/2005WO2005080549A2 Trioxacarcins and their use against infections
09/01/2005WO2005080406A2 Compounds for the inhibition of undesired cell proliferation and use thereof
09/01/2005WO2005080399A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
09/01/2005WO2005080398A1 Method for the production of anagrelide hydrochloride
09/01/2005WO2005080397A2 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
09/01/2005WO2005080394A1 4-substituted piperidine derivatives
09/01/2005WO2005080393A1 Compounds and compositions as protein kinase inhibitors
09/01/2005WO2005080392A1 Pyrazoloquinolone derivative and use thereof
09/01/2005WO2005080390A1 Imidazopyridine derivatives as bsr-3 antagonists
09/01/2005WO2005080389A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005080384A2 Benzimidazole derivative and use as aii receptor antagonist
09/01/2005WO2005080383A1 Itraconazole hydrochloride, the preparation and the oral solid composition thereof
09/01/2005WO2005080382A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
09/01/2005WO2005080376A1 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/01/2005WO2005080374A1 New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation
09/01/2005WO2005080373A1 Substituted quinoline compounds
09/01/2005WO2005080372A1 Dihydropyridinone derivatives
09/01/2005WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080366A1 Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors
09/01/2005WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080357A2 Oxazole derivatives, preparation and therapeutic use therof
09/01/2005WO2005080355A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
09/01/2005WO2005080352A2 Quinazoline derivatives and therapeutic use thereof
09/01/2005WO2005080351A1 The preparation and application of a n4-oxycarbonylcytosine derivatives
09/01/2005WO2005080348A1 Novel sulfone amide derivative
09/01/2005WO2005080346A1 Substituted azole derivatives, compositions, and methods of use
09/01/2005WO2005080343A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
09/01/2005WO2005080342A1 Pyridine derivatives and their use as cb2 receptor modulators
09/01/2005WO2005080340A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005WO2005080338A2 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins
09/01/2005WO2005080336A1 Novel benzofurans and indols
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005080332A1 Novel form of fluvastatin sodium
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2005080325A2 Sulfur-containing compositions and processes for making same
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080320A1 Androgen receptor modulators
09/01/2005WO2005080319A1 Hydrazino alcohol derivatives useful as inhibitors of copper-containing amine oxidases
09/01/2005WO2005079868A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
09/01/2005WO2005079862A1 USE OF RESISTIN ANTISENSE OLIGONUCLEOTIDES AND/OR siRNA MOLECULES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
09/01/2005WO2005079858A1 Stable, palatable syrup containing ibuprofen and method of its preparation
09/01/2005WO2005079857A1 Galactomannans and/or glucomannans for increasing the bioavailability of active substances
09/01/2005WO2005079856A1 Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules
09/01/2005WO2005079853A2 Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid
09/01/2005WO2005079852A2 Bacteriostatic esters for topical use
09/01/2005WO2005079851A2 Dopamine-agonist combination therapy with sedatives for improving sleep quality
09/01/2005WO2005079850A1 New combinations of an anti emetic agent and an enkephalinase inhibitor
09/01/2005WO2005079849A2 Compounds for enhanced cancer therapy
09/01/2005WO2005079847A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
09/01/2005WO2005079846A1 NUCLEAR TRANSFER PROMOTER FOR Rac PROTEIN AND METHOD OF SCREENING THE SAME
09/01/2005WO2005079845A1 Preventives for migraine
09/01/2005WO2005079837A1 Methods of modulating il-23 activity; related reagents
09/01/2005WO2005079827A2 Antitumor agent
09/01/2005WO2005079825A1 Oral skin remedy containing cranberry extract as active ingredient
09/01/2005WO2005079817A1 Affinity purified heparin/heparan sulfate for controlling the biological activity of the fgf receptor
09/01/2005WO2005079816A1 An anti-cancer substance of polysaccharides, its preparation method and application
09/01/2005WO2005079815A2 Methods and reagents for treating autosomal dominant diseases of the eye
09/01/2005WO2005079814A1 A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof
09/01/2005WO2005079813A1 Composition for nkt cell activation
09/01/2005WO2005079812A1 Nucleoside phosphonate derivatives useful in the treatment of hiv infections
09/01/2005WO2005079811A1 Improved therapy using a combination of raloxifene and alendronate
09/01/2005WO2005079810A1 USES OF ERβ MODULATORS
09/01/2005WO2005079809A1 Transparent latanoprost eye drops
09/01/2005WO2005079807A1 Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
09/01/2005WO2005079806A1 Use of meloxicam for the treatment of respiratory diseases in pigs
09/01/2005WO2005079805A1 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
09/01/2005WO2005079804A1 Method of stimulating hair growth
09/01/2005WO2005079803A1 Compounds for treatment of cardiovascular diseases
09/01/2005WO2005079802A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005WO2005079797A2 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid
09/01/2005WO2005079796A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
09/01/2005WO2005079795A2 Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders
09/01/2005WO2005079794A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
09/01/2005WO2005079793A1 Prostaglandin d2 antagonist
09/01/2005WO2005079792A1 Preventive or therapeutic agents for severe diabetic retinopathy
09/01/2005WO2005079791A1 Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
1 ... 4555 4556 4557 4558 4559 4560 4561 4562 4563 4564 4565 4566 4567 4568 4569 4570 4571 4572 4573 4574 4575 ... 7860